Vaccines

FDA’s “Gold Standard” Critical for Biopharma R&D

September 08, 2020

Industry leaders insist they will maintain high standards for clinical trials and regulatory submissions for new vaccines and therapeutics to combat COVID-19.

BIO Message: Keep Drug Development Independence

September 03, 2020

BIO leaders urge biopharmaceutical companies to apply scientific principles in seeking drug and vaccine approvals.

Preparing Pandemic Vaccine Capacity

September 03, 2020

Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.

Biopharma Gears Up Pandemic Response

September 02, 2020

Amid high expectations for a vaccine, bio/pharma readies capacity, weighs pressures.

J&J to Supply the Government of Canada with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

Negotiations for a final advance purchase agreement where the Government of Canada purchases the vaccine candidate on a not-for-profit basis for emergency pandemic use are underway.

Moderna in Discussions to Supply Japan with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

The vaccine will be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical starting in the first half of 2021 if the vaccine candidate receives regulatory approval.

Novavax to Supply Canada with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

Novavax and the Government of Canada will finalize an advanced purchase agreement under which Novavax will supply doses of NVX-CoV2373 to Canada beginning in the second quarter of 2021.

Oxford Biomedica Collaborates with AstraZeneca for COVID-19 Vaccine Candidate Manufacturing

September 01, 2020

Oxford Biomedica will reserve capacity for AstraZeneca in three of its manufacturing suites in its new commercial manufacturing center, Oxbox, for 18 months.

Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19 Vaccines and Therapeutics

August 26, 2020

The contract is valued at $106.3 million and is supported by Operation Warp Speed.

EC and Moderna Conclude Exploratory Talks on Vaccine Supply for Europe

August 26, 2020

The European Commission (EC) and Moderna have concluded exploratory talks on the potential purchase of Moderna’s COVID-19 vaccine candidate for Europeans.